From April 12, 2024 to May 13, 2024, the company has repurchased 350,000 shares, representing 2.23% for ¥868.86 million. With this, the company has completed the repurchase of 350,000 shares, representing 2.23% for ¥868.86 million under the buyback announced on April 12, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,309 JPY | +1.27% |
|
+3.03% | +21.21% |
1st Jan change | Capi. | |
---|---|---|
+21.21% | 218M | |
+19.51% | 42.97B | |
+24.56% | 22.16B | |
+19.29% | 15.45B | |
+20.33% | 14.56B | |
+55.51% | 13.03B | |
-0.05% | 6.79B | |
-11.35% | 6.46B | |
+17.73% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 4577 Stock
- News Daito Pharmaceutical Co.,Ltd.
- Tranche Update on Daito Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on April 12, 2024.